Pfizer Inc. (PFE) makes a promising vaccine investment

Pfizer Inc. (NYSE: PFE) will collaborate on the development of a potential Lyme disease vaccine. The increasing number of people infected with this disease can assure a consistent demand for such a medicine. Pfizer Inc. (PFE) joined forces with Valneva in 2020 after the latter disclosed positive results from a phase II study of the […]

Investors Are Once Again Showing Interest In Vaccine Stocks

Once again, pharmaceutical companies related to Covid-19 vaccines have been quite closely related. Novavax Inc. (NVAX) leapt by +2.93% to $120.27 on Tuesday. The U.S. biotechnology firm’s latest coronavirus vaccine candidate could be accepted next year, subject, of course, to good outcomes from the recently completed Phase 3 clinical trial. Pfizer Inc. (PFE) was up […]

Stocks Of Several Vaccine Makers Dropped In Pre-Holiday Session

Pfizer Inc (PFE) was down -0.45 percent to $37.27 whereas it’s German partner BioNTech SE (BNTX) fell by 3.10 percent to $96.96. On Thursday, the French High Health Authority (HAS) approved the COVID-19 vaccine developed by Pfizer and BioNTech laboratories to be used, the last regulatory move prior to the start of vaccination in France […]